Home

Mangoceuticals, Inc. - Common Stock (MGRX)

4.2700
0.00 (0.00%)

Mangoceuticals, Inc. is a biotechnology company focused on developing innovative wellness and lifestyle products that leverage the benefits of natural ingredients

The company specializes in formulating and marketing supplements aimed at enhancing men's health, vitality, and overall quality of life. By combining cutting-edge research with the power of nature, Mangoceuticals aims to provide consumers with effective and safe solutions for improving their well-being, all while promoting a healthier lifestyle. Through its commitment to quality and sustainability, the company seeks to establish itself as a leader in the health and wellness industry.

SummaryNewsPress ReleasesChartHistoricalFAQ
Top 3 Risk Off Stocks Which Could Rescue Your Portfolio This Quarterbenzinga.com
Via Benzinga · October 17, 2024
12 Consumer Staples Stocks Moving In Friday's Pre-Market Sessionbenzinga.com
Via Benzinga · October 11, 2024
12 Consumer Staples Stocks Moving In Thursday's After-Market Sessionbenzinga.com
Via Benzinga · October 10, 2024
12 Consumer Staples Stocks Moving In Tuesday's After-Market Sessionbenzinga.com
Via Benzinga · October 8, 2024
12 Consumer Staples Stocks Moving In Friday's After-Market Sessionbenzinga.com
Via Benzinga · October 4, 2024
Men's Telehealth Company's Plans To Change Men's Wellness
Men's Telehealth Company's Plans To Change Men's Wellness
Via News Direct · September 26, 2024
MGRX Stock Earnings: Mangoceuticals Reported Results for Q2 2024investorplace.com
Mangoceuticals just reported results for the second quarter of 2024.
Via InvestorPlace · August 15, 2024
11 Consumer Staples Stocks Moving In Friday's Intraday Sessionbenzinga.com
Via Benzinga · October 4, 2024
12 Consumer Staples Stocks Moving In Thursday's Pre-Market Sessionbenzinga.com
Via Benzinga · October 3, 2024
12 Consumer Staples Stocks Moving In Tuesday's Intraday Sessionbenzinga.com
Via Benzinga · October 1, 2024
Prescribing The Future: How MangoRx Is Shaking Up Telemedicine With A Fresh Platform
Prescribing The Future: How MangoRx Is Shaking Up Telemedicine With A Fresh Platform
Via News Direct · September 5, 2024
This Men’s Telehealth Company Has A Unique Take On Telehealth And Products
This Men’s Telehealth Company Has A Unique Take On Telehealth And Products
Via News Direct · July 25, 2024
Why Is Mangoceuticals (MGRX) Stock Up 130% Today?investorplace.com
MGRX stock is up today after the company announced promising clinical trial results for its oral weight-loss drugs.
Via InvestorPlace · May 21, 2024
Emerging Telemedicine Leaders: Stocks Shaping Healthcare's Digital Future
Emerging Telemedicine Leaders: Stocks Shaping Healthcare's Digital Future
Via News Direct · July 25, 2024
Erectile Function Vs Erectile Dysfunction: How MangoRx’s (NASDAQ: MGRX) Product Sets Itself Apart and Caters to a Large Market (Pun Intended)
Erectile Function Vs Erectile Dysfunction: How MangoRx’s (NASDAQ: MGRX) Product Sets Itself Apart and Caters to a Large Market (Pun Intended)
Via News Direct · July 10, 2024
Why Stitch Fix Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · June 5, 2024
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesdayinvestorplace.com
Pre-market stock movers are a hot topic as investors return to trading on Tuesday following the long holiday weekend!
Via InvestorPlace · May 28, 2024
12 Consumer Staples Stocks Moving In Wednesday's Intraday Sessionbenzinga.com
Via Benzinga · May 22, 2024
Why Urban Outfitters Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · May 22, 2024
12 Consumer Staples Stocks Moving In Wednesday's Pre-Market Sessionbenzinga.com
Via Benzinga · May 22, 2024
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesdayinvestorplace.com
Pre-market stock movers are worth checking out on Wednesday as we offer up all the latest news sending shares higher and lower this morning!
Via InvestorPlace · May 22, 2024
Gold Moves Lower; Macy's Boosts 2024 Forecastbenzinga.com
Via Benzinga · May 21, 2024
Why James Hardie Industries Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Sessionbenzinga.com
Via Benzinga · May 21, 2024
Crude Oil Moves Lower; Lowe's Earnings Top Viewsbenzinga.com
Via Benzinga · May 21, 2024
Mangoceuticals Develops Oral GLP-1s: Stock Soarsbenzinga.com
Mangoceuticals announced the development of proprietary oral formulations of Semaglutide ("Slim") and Tirzepatide ("Trim") to aid in weight management and said it plans to have the products available for customers in the beginning of the 3rd quarter with ‘Slim' and ‘Trim' priced at $299/month and $399/month, respectively.
Via Benzinga · May 21, 2024